Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Curasen Therapeutics Announces $54.5M Series A Financing With Industry Veterans At Helm To Develop Drugs Targeting Novel Mechanism For The Treatment Of Neurodegenerative Diseases
Venture Capital

Curasen Therapeutics Announces $54.5M Series A Financing With Industry Veterans At Helm To Develop Drugs Targeting Novel Mechanism For The Treatment Of Neurodegenerative Diseases

by prnewswire.com posted 8months ago 245 views
SAN MATEO, Calif., Oct. 17, 2018 /PRNewswire/ -- CuraSen Therapeutics, Inc., a privately held biotechnology company focused on developing therapies to treat neurodegenerative diseases, today announced the closing of a $54.5 million Series A financing. Led by New Leaf Venture Partners, the ...

In this article